Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05632068

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05632068
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05632068. Randomized; no masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
Condition
Hyperlipidemias
Condition
Obesity
Condition
Body Fat Disorder
Intervention (Drug)
Xian-Hua-Cha
Lead sponsor
Chang Gung Memorial Hospital (class: other)

Record details

Record id
cardio:ct-nct05632068
Content hash
8fe4e7cb76f0a4bc993b7f6ddeecac5c784347bb97ac471faf2c8af3a6493248